High-performance liquid chromatography of some basic drugs on a n-octadecylphosphonic acid modified magnesia-zirconia stationary phase.
The high-performance liquid chromatographic behavior of some basic drugs was studied on a n-octadecylphosphonic acid modified magnesia-zirconia (C18PZM) stationary phase. The effect of mobile phase variables such as methanol content, ionic strength, and pH on their chromatographic behavior was investigated. The retention mechanism of basic drugs on the stationary phase was elucidated. The results indicate that both hydrophobic and cation-exchange interactions contribute to solute retention under most chromatographic conditions. The inherent Brönsted-acid sites and also the adsorbed Lewis base anionic buffer constituents on accessible ZM surface Lewis acid sites play a role in the retention of ionized solutes by cation-exchange interaction. However, especially at high mobile phase pH, the retention of basic drugs depends mainly on hydrophobic interactions between solutes and support. Separations of the basic drugs on the C18PZM phase by a predominantly reversed-phase retention mode were very promising. The mixed-mode retention feature on this phase, as a result of the adsorbed Lewis base anionic buffer constituents acting as sites for cation-exchange, could also be very useful, e.g. for enhancing the chromatographic selectivity of such analytes. The C18PZM seems to be an excellent alternative to silica-based reversed-phase stationary phase for the separation of strongly basic solutes.
He
Hai-Bo
HB
Department of Chemistry, Wuhan University, Wuhan, PR China.
Feng
Yu-Qi
YQ
Da
Shi-Lu
SL
Hu
Zhi-Xiong
ZX
Qu
Li
L
D002746:Chlorpromazine / Q000302:isolation & purification; D004316:Doxepin / Q000302:isolation & purification; D004355:Drug Stability; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D008277:Magnesium Oxide; D009930:Organic Chemicals / Q000737:chemistry* / Q000302:isolation & purification*; D063065:Organophosphonates / Q000737:chemistry* / Q000302:isolation & purification*; D004364:Pharmaceutical Preparations / Q000737:chemistry* / Q000302:isolation & purification*; D014700:Verapamil / Q000302:isolation & purification; D015040:Zirconium
D007202:Indicators and Reagents; D009930:Organic Chemicals; D063065:Organophosphonates; D004364:Pharmaceutical Preparations; D004316:Doxepin; D008277:Magnesium Oxide; D015040:Zirconium; D014700:Verapamil; C028541:zirconium oxide; D002746:Chlorpromazine